Protein Z polymorphisms associated with vaso-occlusive crisis in young sickle cell disease patients

被引:7
作者
Mahdi, Najat [2 ]
Abu-Hijleh, Tala M. [1 ]
Abu-Hijleh, Farah M. [1 ]
Sater, Mai S. [1 ]
Al-Ola, Khadija [2 ]
Almawi, Wassim Y. [1 ]
机构
[1] Arabian Gulf Univ, Coll Med & Med Sci, Dept Med Biochem, Manama, Bahrain
[2] Dept Pediat, Manama, Bahrain
关键词
Protein Z; Sickle cell disease; Vaso-occlusive crisis; Z GENE POLYMORPHISMS; Z PLASMA-LEVELS; ISCHEMIC-STROKE; PAIN MANAGEMENT; GROWTH-FACTOR; Z DEFICIENCY; Z ANTIBODIES; RISK-FACTOR; THROMBOSIS; INHIBITOR;
D O I
10.1007/s00277-012-1474-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We investigated the association of protein Z (PZ) promoter (rs3024718, rs3024719, and rs3024731) and intron (rs3024735; G79A) SNPs with sickle cell disease (SCD) vaso-occlusive crisis (VOC). Study subjects included 239 SCD patients with VOC and 138 pain-free SCD control patients. PZ genotyping was done by allelic discrimination (real-time PCR) assays. The minor allele frequency of rs3024718 (P = 0.03), rs3024719 (P = 0.02), rs3024731 (P < 0.001), and rs3024735 (P < 0.001) were higher in VOC patients than control SCD patients. Significant differences in the distribution of rs3024731 (P = 0.028) and rs3024735 (P = 0.045) genotypes were seen between VOC and steady-state SCD patients. This association remained significant after adjusting for gender, HbS, and HbF. Four-locus (rs3024718/rs3024719/rs3024731/rs3024735) PZ haplotypes analysis demonstrated increased frequency of GAAA (P = 0.024), AGAA (P = 0.011), and GGTG (P = 0.002), and reduced frequency of AGTG haplotype (P = 0.001) in VOC than in steady-state control patients, thereby conferring disease susceptibility and protective nature to these haplotypes, respectively. Of these, only AGTG (P (c) = 0.001) and GGTG (P (c) = 0.018) remained significant after applying the Bonferroni correction. In conclusion, specific PZ variants and haplotypes are significantly associated with SCD VOC.
引用
收藏
页码:1215 / 1220
页数:6
相关论文
共 38 条
[31]   Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes [J].
Shet, AS ;
Aras, O ;
Gupta, K ;
Hass, MJ ;
Rausch, DJ ;
Saba, N ;
Koopmeiners, L ;
Key, NS ;
Hebbel, RP .
BLOOD, 2003, 102 (07) :2678-2683
[32]   A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis [J].
Sofi, Francesco ;
Cesari, Francesca ;
Abbate, Rosanna ;
Gensini, Gian Franco ;
Broze, George, Jr. ;
Fedi, Sandra .
THROMBOSIS AND HAEMOSTASIS, 2010, 103 (04) :749-756
[33]   Unique secretion mode of human protein Z: its Gla domain is responsible for inefficient, vitamin K-dependent and warfarin-sensitive secretion [J].
Souri, Masayoshi ;
Iwata, Hiroki ;
Zhang, Wei Guang ;
Ichinose, Akitada .
BLOOD, 2009, 113 (16) :3857-3864
[34]   Protein Z gene polymorphisms, protein Z concentrations, and ischemic stroke [J].
Staton, J ;
Sayer, M ;
Hankey, GJ ;
Cole, V ;
Thom, J ;
Eikelboom, JW .
STROKE, 2005, 36 (06) :1123-1127
[35]  
Taha HM, 2011, SAUDI MED J, V32, P152
[36]   Low protein Z levels but not the protein Z gene G79A polymorphism are a risk factor for ischemic stroke [J].
van Goor, M. P. J. ;
Dippel, D. W. J. ;
Jie, K. S. -G. ;
de Maat, M. P. M. ;
Koudstaal, P. J. ;
Leebeek, F. W. G. .
THROMBOSIS RESEARCH, 2008, 123 (02) :213-218
[37]   Protein Z, a protein seeking a pathology [J].
Vasse, Marc .
THROMBOSIS AND HAEMOSTASIS, 2008, 100 (04) :548-556
[38]   Prothrombotic phenotype of protein Z deficiency [J].
Yin, ZF ;
Huang, ZF ;
Cui, JS ;
Fiehler, R ;
Lasky, N ;
Ginsburg, D ;
Broze, GJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6734-6738